Safety and Efficacy of CJ-50300 in Healthy Volunteers
NCT00607243
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
123
Enrollment
OTHER
Sponsor class
Conditions
Smallpox
Interventions
BIOLOGICAL:
smallpox vaccine CJ-50300
Sponsor
Seoul National University Hospital
Collaborators
[object Object]